Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALT Altimmune, Inc.

未开盘 11-02 16:00:00 EST

2.02

-0.02

-0.98%

盘后2.02

+0.000.00%

19:53 EST

最高2.11	最低2.01	成交量274.06万
今开2.07	昨收2.04	日振幅4.72%
总市值3.92亿	流通市值3.31亿	总股本1.94亿
成交额558.92万	换手率1.67%	流通股本1.64亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":2.02,"timestamp":1793653200000,"preClose":2.04,"halted":0,"volume":2740632,"hourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.02,"latestTime":"19:53 EST","volume":25656,"amount":51912.778,"timestamp":1793667212177,"change":0,"changeRate":0,"amplitude":0.024752},"delay":0,"changeRate":-0.00980392156862746,"floatShares":164000000,"shares":194000000,"eps":-0.76,"marketStatus":"未开盘","change":-0.02,"latestTime":"11-02 16:00:00 EST","open":2.07,"high":2.1063,"low":2.01,"amount":5589223.5238704,"amplitude":0.047206,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.76,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793696400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.04,"preHourTrading":{"tag":"盘前","latestPrice":2.11,"preClose":2.04,"latestTime":"09:25 EST","volume":22792,"amount":47981.877944,"timestamp":1793629556620,"change":0.07,"changeRate":0.034314,"amplitude":0.044118},"postHourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.02,"latestTime":"19:53 EST","volume":25656,"amount":51912.778,"timestamp":1793667212177,"change":0,"changeRate":0,"amplitude":0.024752},"volumeRatio":0.721119,"impliedVol":0.3918,"impliedVolPercentile":0.0319},"requestUrl":"/m/hq/s/ALT","defaultTab":"news","newsList":[{"id":"2676501035","title":"RootData：ALT 将于一周后解锁价值约 213 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2676501035","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676501035?lang=zh_cn&edition=full","pubTime":"2026-10-19 17:00","pubTimestamp":1792400404,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 10 月 26 日 8 时解锁约 24659 万枚代币，价值约 213 万美元。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2297307","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","ALT","TWEB","LU1878469433.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668284974","title":"RootData：ALT 将于一周后解锁价值约 176 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2668284974","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668284974?lang=zh_cn&edition=full","pubTime":"2026-09-19 11:00","pubTimestamp":1789786801,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 09 月 26 日 8 时解锁约 24659 万枚代币，价值约 176 万美元。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2290888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","LU1878469433.USD","BK4139","BK4599","TWEB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665535012","title":"功能性治愈率最高61%！乙肝新药中国数据出炉 但7500万患者的“治愈梦”仍有门槛","url":"https://stock-news.laohu8.com/highlight/detail?id=2665535012","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665535012?lang=zh_cn&edition=full","pubTime":"2026-09-05 12:14","pubTimestamp":1788581677,"startTime":"0","endTime":"0","summary":"【功能性治愈率最高61%！乙肝新药中国数据出炉 但7500万患者的“治愈梦”仍有门槛】8月31日—9月5日，在新加坡召开的亚洲肝病学峰会（AHS）暨HBV（乙型肝炎病毒）治愈科学会议上，反义寡核苷酸（ASO）药物Bepirovirsen全球Ⅲ期研究（B-Well研究）的中国人群数据完成了全球首秀：中国慢乙肝患者功能性治愈率最高可达61%，疗效与安全性趋势与全球数据一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609053865995314.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609053865995314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","BK4532","CDE","BK4200","XME","CHB","BK4588","GSKH","LU1829250122.USD","LU1223082196.USD","BK4599","BK4017","ASO","LU1223082519.USD","BK4585","ALT","LU1223083913.SGD","GDXJ","BK4561","SIL","BK4007","LU1878469433.USD","SGDM","GSK.UK","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660192244","title":"RootData：ALT 将于一周后解锁价值约 144 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2660192244","media":"链捕手","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660192244?lang=zh_cn&edition=full","pubTime":"2026-08-19 11:00","pubTimestamp":1787108402,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 08 月 26 日 8 时解锁约 24659 万枚代币，价值约 144 万美元。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2283676","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132863801","title":"Altimmune盘前飙升17%，其药物治疗酒精使用障碍中期研究达成主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1132863801","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132863801?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:13","pubTimestamp":1785237189,"startTime":"0","endTime":"0","summary":"Altimmune（ALT）盘前交易时段股价大幅上涨17%。这一强劲表现源于公司公布了一项积极进展：其在研药物针对酒精使用障碍的中期研究，成功达到了主要终点目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4599","BK4139","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170025455","title":"Altimmune旗下Pemvidutide 2.4mg在二期试验中显著减少重度饮酒天数","url":"https://stock-news.laohu8.com/highlight/detail?id=1170025455","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170025455?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:06","pubTimestamp":1785236798,"startTime":"0","endTime":"0","summary":"Altimmune, Inc.宣布，其研发的Pemvidutide（2.4毫克剂量）在二期临床试验中取得重大突破。数据显示，该药物能够显著降低受试者的重度饮酒天数。这一结果，为酒精使用障碍的治疗领域带来了新的希望。Pemvidutide作为一种创新疗法，其潜力正在被逐步验证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199342012","title":"Altimmune公布Pemvidutide治疗酒精使用障碍的Reclaim 2期临床试验取得积极初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1199342012","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199342012?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:03","pubTimestamp":1785236590,"startTime":"0","endTime":"0","summary":"Altimmune宣布，其Pemvidutide药物在针对酒精使用障碍（Alcohol Use Disorder）的Reclaim 2期临床试验中，获得了令人振奋的初步顶线数据。这些积极结果表明，该疗法展现出显著的治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","ALT","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652255112","title":"RootData：ALT 将于一周后解锁价值约 157 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2652255112","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652255112?lang=zh_cn&edition=full","pubTime":"2026-07-19 11:00","pubTimestamp":1784430003,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 07 月 26 日 8 时解锁约 24659 万枚代币，价值约 157 万美元。 ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2277152","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4599","BK4139","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644887058","title":"RootData：ALT 将于一周后解锁价值约 172 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2644887058","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644887058?lang=zh_cn&edition=full","pubTime":"2026-06-19 11:00","pubTimestamp":1781838005,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 06 月 26 日 8 时解锁约 24659 万枚代币，价值约 172 万美元。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2272359","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","ALT","LU1878469433.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153909378","title":"勃林格殷格翰：同步试验中，Survodutide组84.2%患者肝脂肪减少至少30%，显著优于安慰剂组24.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153909378","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153909378?lang=zh_cn&edition=full","pubTime":"2026-06-08 02:31","pubTimestamp":1780857104,"startTime":"0","endTime":"0","summary":"在同步进行的代谢功能障碍相关脂肪性肝病临床试验中，勃林格殷格翰公司宣布了其药物Survodutide的积极数据。结果显示，接受Survodutide治疗的患者中，有高达84.2%的人实现了肝脏脂肪含量减少至少30%的目标。这一疗效数据与安慰剂组形成了鲜明对比——后者仅有24.3%的患者达到相同标准。\n该数据凸显了Survodutide在减少肝脏脂肪堆积方面的显著潜力，为治疗这一日益普遍的肝脏疾病带来了新的希望。随着非酒精性脂肪性肝病领域竞争加剧，包括礼来在内的其他制药巨头也在此赛道积极布局，此次积极结果可能进一步重塑市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2111349929.HKD","LU0471298777.SGD","LLYX","IE00BKPKM429.USD","IE00BN29S564.USD","LU2236285917.USD","LU1868837300.USD","LU2237443978.SGD","SGXZ99366536.SGD","SG9999018857.SGD","LU1804176565.USD","LU0122379950.USD","LU1983299246.USD","IE00B1BXHZ80.USD","LU2237443622.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU2361045086.USD","IE00BWXC8680.SGD","LU0234572021.USD","LU1989771016.USD","LU0225283273.USD","LU0158827781.USD","LU2552382132.HKD","LU2756315664.SGD","LU0114720955.EUR","LU0882574139.USD","LU0320765059.SGD","LU0385154629.USD","SG9999001176.SGD","LU1035775433.USD","LU2491050154.USD","SGXZ81514606.USD","LU1291159041.SGD","LU2552382058.USD","IE00B2B36J28.USD","LU2168564149.EUR","LU2237438978.USD","LU2750360997.AUD","LU1069344957.HKD","IE0004445015.USD","LU2265009873.SGD","LU1093756325.SGD","SGXZ51526630.SGD","BK4139","LU1366192091.USD","LU0820561818.USD","LU2746668461.USD","LU2028103732.USD","LU2089283258.USD","LU2324357040.USD","LU0320765992.SGD","LU2491049909.HKD","LU0964807845.USD","LU1551013425.SGD","LU1064131342.USD","LU2271345857.HKD","LU0823416689.USD","LU2237443465.HKD","LU2491050071.SGD","IE0001KFT4U8.USD","LU1974910355.USD","LU1917777945.USD","LU1868836914.USD","LU0266013472.USD","LU0787776722.HKD","LU0786609619.USD","LU2211815571.USD","LU0471298694.HKD","LU1280957306.USD","IE00BJJMRZ35.SGD","LU0672654240.SGD","SG9999013999.USD","IE00BK4W5M84.HKD","IE00BJJMRY28.SGD","LU0210536198.USD","LU2461242641.AUD","SG9999014898.SGD","SG9999015986.USD","LU0432979614.USD","LU1868836757.USD","LU0256863811.USD","LU2023250330.USD","LU0689472784.USD","BK4585","LU0061475181.USD","LU1712237335.SGD","LU2213496289.HKD","SG9999014914.USD","LU2106854487.HKD","LU0466842654.USD","LU0256863902.USD","LU0133085943.USD","IE0002141913.USD","LU1093756168.USD","IE00BFSS8Q28.SGD","LU0158827948.USD","IE00BK4W5L77.USD","LU0820562030.AUD","LU0354030438.USD","LU1061106388.HKD","LU2417539215.USD","ELIL","LU1023059063.AUD","LU2361044949.HKD","SG9999001176.USD","IE00BJLML261.HKD","IE00BJJMRX11.SGD","LU0323591593.USD","LU2750360641.GBP","LU2456880835.USD","IE00B1XK9C88.USD","LU2168564065.EUR","LU2756315318.SGD","LU2357305700.SGD","LU0889565916.HKD","LU2471134952.CNY","LU1623119135.USD","LU0006306889.USD","BK4588","LU2264538146.SGD","LLYZ","LU0203201768.USD","BK4516","LU2112291526.USD","LU2468319806.SGD","SG9999014906.USD","LU0943347566.SGD","LU0079474960.USD","LU2237443895.HKD","LU1988902786.USD","LU2168564222.USD","LU1267930730.SGD","LU2552382215.SGD","LU0289739699.SGD","SG9999015952.SGD","LU0094547139.USD","LU0316494557.USD","GB00BDT5M118.USD","LU2602419157.SGD","SG9999015978.USD","BK4581","LLY","LU2168563687.JPY","LU0882574055.USD","LU2168564495.EUR","LU0109394709.USD","LU2471134879.HKD","SG9999015945.SGD","IE0005OL40V9.USD","IE00B4R5TH58.HKD","LU2237443382.USD","LU0203202063.USD","LU0198837287.USD","LU1323610961.USD","LU0417517546.SGD","LU0353189680.USD","LU0109391861.USD","ALT","BK4534","LU1232071149.USD","LU0238689110.USD","LU1127390331.HKD","ELIS","BK4599","LU1720051017.SGD","LU1720051108.HKD","LU2023251221.USD","LU2063271972.USD","LU1548497426.USD","SG9999018865.SGD","IE00B7KXQ091.USD","LU0708995401.HKD","LU1551013342.USD","LU2361044865.SGD","LU2087625088.SGD","LU0353189763.USD","SGXZ31699556.SGD","LU0823434740.USD","IE00B4JS1V06.HKD","LU1057294990.SGD","IE00BKDWB100.SGD","LU1878469433.USD","LU1868837136.USD","LU2089284900.SGD","BK4007","LU0058720904.USD","LU0354030511.USD","LU2108987350.USD","IE0009355771.USD","LU2360106947.USD","LU0096364046.USD","LU0097036916.USD","LLII","IE0004445239.USD","IE00BFTCPJ56.SGD","LU0683600562.USD","LU1868836591.USD","LU2896262040.SGD","BK4533","LU1629891620.HKD","LU2746668974.SGD","LU0640476718.USD","LU2471134523.USD","LU2237443549.SGD","LU1814569148.SGD","LU2023250504.SGD","SG9999017495.SGD","LU2462157665.USD","LU0823434583.USD","LU1145028129.USD","LU0820561909.HKD","SG9999014880.SGD","IE00B775H168.HKD","SGXZ57979304.SGD","IE00BFSS7M15.SGD","LU2471134796.USD","LU2089984988.USD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175987912","title":"勃林格殷格翰Survodutide药物显示内脏脂肪减少34%、肝脏脂肪减少63%，并最大限度减少瘦体重流失","url":"https://stock-news.laohu8.com/highlight/detail?id=1175987912","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175987912?lang=zh_cn&edition=full","pubTime":"2026-06-08 02:30","pubTimestamp":1780857032,"startTime":"0","endTime":"0","summary":"勃林格殷格翰公布的数据显示，其药物Survodutide在临床试验中取得了显著效果，实现了内脏脂肪减少34%和肝脏脂肪减少63%，同时有效控制了瘦体重的流失。这一结果凸显了该药物在治疗与肥胖相关代谢疾病方面的潜力，可能为患者提供一种新的有效治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1868836914.USD","LU2746668974.SGD","LU2108987350.USD","LU0672654240.SGD","IE00B4JS1V06.HKD","LU0097036916.USD","LU0266013472.USD","IE00BJJMRX11.SGD","LU1720051108.HKD","SG9999001176.USD","LU0456855351.SGD","LU2461242641.AUD","LU2552382215.SGD","LU2471134879.HKD","LU0210536198.USD","LU0889565916.HKD","LU1551013425.SGD","LU0094547139.USD","LU1712237335.SGD","LU1548497426.USD","BK4516","LU2264538146.SGD","LU2265009873.SGD","IE00BWXC8680.SGD","LU2089284900.SGD","LU0471298777.SGD","LU0203202063.USD","LU0320765059.SGD","LU1291159041.SGD","LU0882574139.USD","LU1366192091.USD","LU0122379950.USD","LU1069344957.HKD","LU0106261372.USD","LU2756315664.SGD","LU0823434583.USD","LU0061475181.USD","LU0114720955.EUR","LU0198837287.USD","LU0683600562.USD","LU0353189680.USD","LU0006306889.USD","LU0133085943.USD","BK4588","LU0823434740.USD","LU1868836757.USD","SG9999014914.USD","LU2471134523.USD","IE00BN29S564.USD","SG9999015986.USD","LU2213496289.HKD","LU2023251221.USD","LU0320765992.SGD","LU1267930730.SGD","SG9999017495.SGD","IE00BK4W5L77.USD","LU2168564222.USD","IE00BJJMRY28.SGD","LU1868837136.USD","LU1023059063.AUD","LU1093756168.USD","LU1878469433.USD","LU0786609619.USD","LU1057294990.SGD","LU1814569148.SGD","IE00B7KXQ091.USD","LU0823416689.USD","LU2324357040.USD","BK4533","BK4534","LU0787776722.HKD","IE0009355771.USD","LU2168563687.JPY","SGXZ81514606.USD","LU2089283258.USD","IE00BKDWB100.SGD","LU2237438978.USD","LU2491050071.SGD","LU0109391861.USD","LU2552382058.USD","LU1232071149.USD","LU2417539215.USD","LU0820561818.USD","LU0158827948.USD","LU0256863811.USD","LU1917777945.USD","LU2087625088.SGD","LU2750360997.AUD","LU0964807845.USD","LU0432979614.USD","LU0158827781.USD","LU0225283273.USD","LU0353189763.USD","LU2028103732.USD","LU2468319806.SGD","LU2106854487.HKD","IE00BFSS7M15.SGD","LU2361045086.USD","ALT","LU2168564065.EUR","LU2237443549.SGD","BK4599","LU2552382132.HKD","SG9999014880.SGD","LU0289739699.SGD","SGXZ57979304.SGD","LU2456880835.USD","LU2750360641.GBP","SG9999013999.USD","BK4139","LU0640476718.USD","IE0004445239.USD","LU0109394709.USD","SGXZ51526630.SGD","LU2237443895.HKD","IE00BJT1NW94.SGD","LU2271345857.HKD","LU1323610961.USD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU0471298694.HKD","LU2471134796.USD","IE00B2B36J28.USD","LU1061106388.HKD","IE00BKPKM429.USD","LLII","LU0354030438.USD","LU1720051017.SGD","SGXZ31699556.SGD","LU0203201768.USD","GB00BDT5M118.USD","LU1035775433.USD","SG9999014906.USD","LU2023250504.SGD","IE00BFSS8Q28.SGD","LU1145028129.USD","LU1804176565.USD","LU2491049909.HKD","LU1623119135.USD","BK4585","SG9999015945.SGD","LU2360106947.USD","LU1983299246.USD","LLYX","LU2023250330.USD","LU2361044949.HKD","SG9999001176.SGD","IE00B1BXHZ80.USD","LU0234572021.USD","LU0708995401.HKD","LU1988902786.USD","LU0096364046.USD","LU2896262040.SGD","SG9999015952.SGD","LU2237443978.SGD","BK4581","LU0256863902.USD","LU2111349929.HKD","LU0323591593.USD","LU0820561909.HKD","LU1551013342.USD","LU2756315318.SGD","LU2361044865.SGD","LU2237443382.USD","LU1127390331.HKD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4007","LU1989771016.USD","LLY","ELIS","IE0004445015.USD","LU2211815571.USD","LU0238689110.USD","LU2357305700.SGD","SG9999014898.SGD","LU2491050154.USD","LU0354030511.USD","LU2471134952.CNY","LU0882574055.USD","SGXZ99366536.SGD","LU1868836591.USD","LU2462157665.USD","LLYZ","IE00BK4W5M84.HKD","LU2237443622.USD","SG9999018857.SGD","IE0001KFT4U8.USD","LU1629891620.HKD","LU1868837300.USD","LU1974910355.USD","LU2168564149.EUR","SG9999018865.SGD","SG9999015978.USD","LU0689472784.USD","LU0079474960.USD","LU2237443465.HKD","ELIL","LU0316494557.USD","LU2602419157.SGD","LU0385154629.USD","IE00B4R5TH58.HKD","LU2112291526.USD","LU0820562030.AUD","LU0466842654.USD","LU2063271972.USD","IE0002141913.USD","IE0005OL40V9.USD","LU1280957306.USD","IE00B1XK9C88.USD","LU2168564495.EUR","LU2746668461.USD","LU1093756325.SGD","LU2236285917.USD","IE00B775H168.HKD","LU0943347566.SGD","IE00BJLML261.HKD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636889164","title":"RootData：ALT 将于一周后解锁价值约 165 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2636889164","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636889164?lang=zh_cn&edition=full","pubTime":"2026-05-19 11:00","pubTimestamp":1779159604,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 05 月 26 日 8 时解锁约 24659 万枚代币，价值约 165 万美元。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2265686","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1878469433.USD","BK4599","ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518682201","title":"Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518682201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518682201?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:21","pubTimestamp":1741630882,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时21分，Altimmune, Inc.股票出现波动，股价大幅跳水5.12%。截至发稿，该股报5.29美元/股，成交量148.018万股，换手率1.92%，振幅4.90%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5934.70%、3845.43%、1003.65%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517430971","title":"Altimmune, Inc.2024财年实现净利润-95.06百万美元，同比减少7.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517430971?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363235,"startTime":"0","endTime":"0","summary":"3月8日，Altimmune, Inc.公布财报，公告显示公司2024财年净利润为-95.06百万美元，同比减少7.47%；其中营业收入为20000.00美元，同比减少95.31%，每股基本收益为-1.34美元。从资产负债表来看，Altimmune, Inc.总负债15.80百万美元，其中短期债务279000.00美元，资产负债比为0.09，流动比率为0.14。机构评级：截至2025年3月8日，当前有8家机构对Altimmune, Inc.目标价做出预测，其中目标均价为22.38美元，其中最低目标价为12.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517319420","title":"Altimmune, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517319420?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:05","pubTimestamp":1741287928,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时05分，Altimmune, Inc.股票出现波动，股价大幅下挫5.07%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4920.76%、3757.89%、255.79%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为125.28%、122.63%、71.44%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4599","LU1878469433.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516651619","title":"HC Wainwright & Co.：重申Altimmune(ALT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516651619?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:55","pubTimestamp":1741024555,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Altimmune(ALT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04015548498807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516580806","title":"Altimmune, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516580806?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:53","pubTimestamp":1741017238,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分，Altimmune, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报6.32美元/股，成交量54.6719万股，换手率0.77%，振幅5.19%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2916.94%、141.90%、133.69%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为206.20%、70.53%、50.09%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","LU1878469433.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385796","title":"Altimmune, Inc.盘中异动 早盘股价大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385796?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:35","pubTimestamp":1740666911,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分，Altimmune, Inc.股票出现波动，股价快速上涨6.06%。截至发稿，该股报6.30美元/股，成交量22.7561万股，换手率0.32%，振幅4.55%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Alector, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为430.02%、92.85%、67.12%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为16.42%、15.14%、14.83%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223511abdf6f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223511abdf6f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4139","ALT","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127825329","title":"Altimmune 2024年第四季度GAAP每股收益为$(0.33)，符合预期，收入同比下降至$5.00千，现金及短期投资$131.9百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1127825329","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127825329?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:07","pubTimestamp":1740658067,"startTime":"0","endTime":"0","summary":"Altimmune报告2024年第四季度每股亏损为$，符合分析师的共识预期。公司本季度报告收入为$5.00千，与去年同期的$37.00千相比下降了86.49%。以上内容来自Benzinga Earnings专栏，原文如下：Altimmune  reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 38.89 percent increase over losses of $ per share from the same period last year.  The company reported $5.00 thousand in sales this quarter. This is a 86.49 percent decrease over sales of $37.00 thousand the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Altimmune 2024年第四季度GAAP每股收益为$(0.33)，符合预期，收入同比下降至$5.00千，现金及短期投资$131.9百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514148800","title":"Altimmune, Inc.盘中异动 股价大跌5.07%报5.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514148800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514148800?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:32","pubTimestamp":1740501166,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时32分，Altimmune, Inc.股票出现异动，股价急速下跌5.07%。截至发稿，该股报5.80美元/股，成交量100.272万股，换手率1.41%，振幅6.87%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1390.94%、1116.23%、913.93%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003246abdc9ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003246abdc9ada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altimmune.com","stockEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":-0.2614},{"period":"3month","weight":-0.342},{"period":"6month","weight":-0.3804},{"period":"1year","weight":-0.5012},{"period":"ytd","weight":-0.4404}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide（原名ALT-801）是一种GLP-1/胰高血糖素双受体激动剂，正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎（“MASH”），以前称为非酒精性脂肪性肝炎（“NASH”）。","yearOnYearQuotes":[{"month":1,"riseRate":0.421053,"avgChangeRate":0.021325},{"month":2,"riseRate":0.368421,"avgChangeRate":-0.012068},{"month":3,"riseRate":0.368421,"avgChangeRate":-0.06468},{"month":4,"riseRate":0.368421,"avgChangeRate":-0.055226},{"month":5,"riseRate":0.526316,"avgChangeRate":0.069937},{"month":6,"riseRate":0.368421,"avgChangeRate":-0.000321},{"month":7,"riseRate":0.368421,"avgChangeRate":0.036187},{"month":8,"riseRate":0.473684,"avgChangeRate":0.103635},{"month":9,"riseRate":0.2,"avgChangeRate":-0.11405},{"month":10,"riseRate":0.25,"avgChangeRate":0.016633},{"month":11,"riseRate":0.4,"avgChangeRate":-0.007566},{"month":12,"riseRate":0.526316,"avgChangeRate":0.184275}],"exchange":"NASDAQ","name":"Altimmune, Inc.","nameEN":"Altimmune, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Altimmune, Inc.,ALT,Altimmune, Inc.股票,Altimmune, Inc.股票老虎,Altimmune, Inc.股票老虎国际,Altimmune, Inc.行情,Altimmune, Inc.股票行情,Altimmune, Inc.股价,Altimmune, Inc.股市,Altimmune, Inc.股票价格,Altimmune, Inc.股票交易,Altimmune, Inc.股票购买,Altimmune, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}